The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Open accessAbstract
Diseases affecting the anterior segment of the eye are the primary causes of vision impairment and blindness globally. Drug administration through the topical ocular route is widely accepted because of its user/patient friendliness - ease of administration and convenience. However, it remains a significant challenge to efficiently deliver drugs to the eye through this route because of various structural and physiological constraints that restrict the distribution of therapeutic molecules into the ocular tissues. The bioavailability of topically applied ocular medications such as eye drops is typically less than 5%. Developing novel delivery systems to increase the retention time on the ocular surfaces and permeation through the cornea is one of the approaches adopted to boost the bioavailability of topically administered medications. Drug delivery systems based on nanotechnology such as micelles, nanosuspensions, nanoparticles, nanoemulsions, liposomes, dendrimers, niosomes, cubosomes and nanowafers have been investigated as effective alternatives to conventional ocular delivery systems in treating diseases of the anterior segment of the eye. This review discussed different nanotechnology-based delivery systems that are currently investigated for treating and managing diseases affecting the anterior ocular tissues. We also looked at the challenges in translating these systems into clinical use and the prospects of nanocarriers as a vehicle for the delivery of phytoactive compounds to the anterior segment of the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Flaxman, S. R., Bourne, R. R. A., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30393-5 · Cited by 3,477
TFOS DEWS II Definition and Classification Report
Craig, J. P., Nichols, K. K., Akpek, E. K., Caffery, B., Dua, H. S., Joo, C.-K., Liu, Z., Nelson, J. D., Nichols, J. J., Tsubota, K., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.008 · Cited by 3,383
Steinmetz, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30489-7 · Cited by 3,189
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
M. Ways, T., Lau, W., & Khutoryanskiy, V. (2018) · Polymers · doi:10.3390/polym10030267 · Cited by 908
Self-citationOcular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Physico-chemical stability of colloidal lipid particles
Heurtault, B. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00331-4 · Cited by 837
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
Advances in Mucoadhesion and Mucoadhesive Polymers
Khutoryanskiy, V. V. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000388 · Cited by 655
Self-citationRecent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Conjunctivitis: A Systematic Review of Diagnosis and Treatment
Azari, A. A., & Barney, N. P. (2013) · JAMA · doi:10.1001/jama.2013.280318 · Cited by 597
Hyaluronic Acid: Redefining Its Role
Abatangelo, G., Vindigni, V., Avruscio, G., Pandis, L., & Brun, P. (2020) · Cells · doi:10.3390/cells9071743 · Cited by 533
Mukherjee, A., Waters, A. K., Kalyan, P., Achrol, A. S., Kesari, S., & Yenugonda, V. M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198353 · Cited by 493
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Bachu, R., Chowdhury, P., Al-Saedi, Z., Karla, P., & Boddu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 421
Emerging role of nanosuspensions in drug delivery systems
Jacob, S., Nair, A. B., & Shah, J. (2020) · Biomaterials Research · doi:10.1186/s40824-020-0184-8 · Cited by 415
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., CHANGLIN, J., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
The Diagnosis and Treatment of Glaucoma
Schuster, A. K., Erb, C., Hoffmann, E. M., Dietlein, T., & Pfeiffer, N. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0225 · Cited by 399
Ocular complications of topical, peri-ocular, and systemic corticosteroids
Carnahan, M. C., & Goldstein, D. A. (2000) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200012000-00016 · Cited by 379
Li, Y., Kröger, M., & Liu, W. K. (2015) · Nanoscale · doi:10.1039/c5nr02970h · Cited by 376
Nanotechnology-based strategies for treatment of ocular disease
Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 375
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
Trivedi, R., & Kompella, U. B. (2010) · Nanomedicine · doi:10.2217/nnm.10.10 · Cited by 358
Varela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., Fernández-Ferreiro, A., & Otero-Espinar, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 354
Recent advances in ocular drug delivery
Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.736515 · Cited by 335
Nanocarriers for ocular drug delivery: current status and translational opportunity
Gorantla, S., Rapalli, V. K., Waghule, T., Singh, P. P., Dubey, S. K., Saha, R. N., & Singhvi, G. (2020) · RSC Advances · doi:10.1039/d0ra04971a · Cited by 313
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
Kaur, I. P., & Smitha, R. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002997 · Cited by 305
Fernández-García, R., Lalatsa, A., Statts, L., Bolás-Fernández, F., Ballesteros, M. P., & Serrano, D. R. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118817 · Cited by 289
Sivadasan, D., Sultan, M. H., Madkhali, O., Almoshari, Y., & Thangavel, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081291 · Cited by 288
Interaction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287
Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
Vllasaliu, D., Exposito-Harris, R., Heras, A., Casettari, L., Garnett, M., Illum, L., & Stolnik, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.020 · Cited by 252
Functions and Diseases of the Retinal Pigment Epithelium
Yang, S., Zhou, J., & Li, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.727870 · Cited by 252
Jindal, A. B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.028 · Cited by 241
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications
Dave, V., Tak, K., Sohgaura, A., Gupta, A., Sadhu, V., & Reddy, K. R. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.03.017 · Cited by 241
Penetration Enhancers in Ocular Drug Delivery
Moiseev, R. V., Morrison, P. W. J., Steele, F., & Khutoryanskiy, V. V. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11070321 · Cited by 239
Self-citationMicroemulsions: A Potential Drug Delivery System
Ghosh, P., & Murthy, R. (2006) · Current Drug Delivery · doi:10.2174/156720106776359168 · Cited by 231
Maurice, D. M., & Mishima, S. (1984) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-69222-2_2 · Cited by 208
Transscleral delivery of bioactive protein to the choroid and retina.
Ambati, J., Gragoudas, E. S., Miller, J. W., You, T., Miyamoto, K., Delori, F. C., & Adamis, A. P. (2000) · PubMed · Cited by 207
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.007 · Cited by 200
Self-citationGan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 196
de la Fuente, M., Seijo, B., & Alonso, M. J. (2008) · Gene Therapy · doi:10.1038/gt.2008.16 · Cited by 194
Comparison of conjunctival and corneal surface areas in rabbit and human
Watsky, M. A., Jablonski, M. M., & Edelhauser, H. F. (1988) · Current Eye Research · doi:10.3109/02713688809031801 · Cited by 192
In situ gel systems as ‘smart’ carriers for sustained ocular drug delivery
Agrawal, A. K., Das, M., & Jain, S. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.665367 · Cited by 192
(2006) · CRC Press eBooks · doi:10.1201/9781420004816 · Cited by 187
Mofidfar, M., Abdi, B., Ahadian, S., Mostafavi, E., Desai, T. A., Abbasi, F., Sun, Y., Manche, E. E., Ta, C. N., & Flowers, C. W. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120924 · Cited by 184
Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño, S., Csaba, N., Alonso, M. J., & de la Fuente, M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.019 · Cited by 182
Dry Eye Disease and Tear Cytokine Levels—A Meta-Analysis
Roda, M., Corazza, I., Bacchi Reggiani, M. L., Pellegrini, M., Taroni, L., Giannaccare, G., & Versura, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093111 · Cited by 181
Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development
A., A., A., M., & F., P. (2012) · Recent Advances in Novel Drug Carrier Systems · doi:10.5772/50486 · Cited by 180
Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery
Khiev, D., Mohamed, Z. A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G. P., Valapala, M., Kerur, N., Passaglia, C. L., et al. (2021) · Nanomaterials · doi:10.3390/nano11010173 · Cited by 180
Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity
Leblanc, B., Jezequel, S., Davies, T., Hanton, G., & Taradach, C. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1243 · Cited by 179
Han, S., Shen, J.-Q., Gan, Y., Geng, H.-M., Zhang, X.-X., Zhu, C.-L., & Gan, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.98 · Cited by 177
Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy
Yuan, X., Marcano, D. C., Shin, C. S., Hua, X., Isenhart, L. C., Pflugfelder, S. C., & Acharya, G. (2015) · ACS Nano · doi:10.1021/nn506599f · Cited by 177
Prevention and management of glucocorticoid-induced side effects: A comprehensive review
Caplan, A. S., Fett, N. M., Rosenbach, M. A., Werth, V. P., & Micheletti, R. G. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.062 · Cited by 176
Aksungur, P., Demirbilek, M., Denkbaş, E. B., Vandervoort, J., Ludwig, A., & Ünlü, N. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.010 · Cited by 175
Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review
Dubald, M., Bourgeois, S., Andrieu, V., & Fessi, H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010010 · Cited by 174
Designing dendrimers for ocular drug delivery
Spataro, G., Malecaze, F., Turrin, C.-O., Soler, V., Duhayon, C., Elena, P.-P., Majoral, J.-P., & Caminade, A.-M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.10.017 · Cited by 172
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.009 · Cited by 172
Kamei, M., Misono, K., & Lewis, H. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00239-1 · Cited by 169
Irimia, T., Ghica, M. V., Popa, L., Anuța, V., Arsene, A., & Dinu‐Pîrvu, C. (2018) · Polymers · doi:10.3390/polym10111221 · Cited by 169
Van Santvliet, L., & Ludwig, A. (2004) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2003.12.009 · Cited by 167
Zeng, W., Li, Q., Wan, T. Y., Liu, C., Pan, W., Wu, Z., Zhang, G., Pan, J., Qin, M., Lin, Y., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.014 · Cited by 166
Üstündağ-Okur, N., Gökçe, E. H., Bozbıyık, D. İ., Eğrilmez, S., Özer, Ö., & Ertan, G. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.07.013 · Cited by 163
Tatke, A., Dudhipala, N., Janga, K. Y., Balguri, S. P., Avula, B., Jablonski, M. M., & Majumdar, S. (2018) · Nanomaterials · doi:10.3390/nano9010033 · Cited by 159
Considerations for Polymers Used in Ocular Drug Delivery
Allyn, M. M., Luo, R. H., Hellwarth, E. B., & Swindle-Reilly, K. E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.787644 · Cited by 159
Mun, E. A., Morrison, P. W. J., Williams, A. C., & Khutoryanskiy, V. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500332m · Cited by 154
Self-citationFangueiro, J. F., Andreani, T., Egea, M. A., García, M. L., Souto, S. B., Silva, A. M., & Souto, E. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.025 · Cited by 152
Sánchez‐López, E., Egea, M. A., Cano, A. C., Espina, M., Calpena, A. C., Ettcheto, M., Camins, A., Souto, E. B., Silva, A. M., & García, M. L. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.054 · Cited by 152
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
Vaneev, A. N., Tikhomirova, V. E., Chesnokova, N. B., Popova, E. V., Валерьевна, Б. О., Kost, O. A., & Klyachko, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212368 · Cited by 144
Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs
Souto, E. B., Doktorovová, S., González‐Mira, E., Egea, M. A., & García, M. L. (2010) · Current Eye Research · doi:10.3109/02713681003760168 · Cited by 142
Zhang, P., Liu, X., Hu, W., Bai, Y., & Zhang, L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.115 · Cited by 138
Maulvi, F. A., Patil, R., Desai, A. R., Shukla, M. R., Vaidya, R. J., Ranch, K. M., Vyas, B., Shah, S. A., & Shah, D. O. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.01.004 · Cited by 136
Target strategies for drug delivery bypassing ocular barriers
Suri, R., Beg, S., & Kohli, K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101389 · Cited by 134
Challenges and opportunities for drug delivery to the posterior of the eye
Cabrera, F. J., Wang, D. C., Reddy, K., Acharya, G. S., & Shin, C. S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.035 · Cited by 133
Rodrigues, G. A., Lutz, D., Shen, J., Yuan, X., Shen, H., Cunningham, J., & Rivers, H. M. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2519-x · Cited by 132
Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy
Chu, K. S., Schorzman, A. N., Finniss, M. C., Bowerman, C. J., Peng, L., Luft, J. C., Madden, A. J., Wang, A. Z., Zamboni, W. C., & DeSimone, J. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.038 · Cited by 129
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128
Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits
Zafar, A., Ali, J., Bhatnagar, A., Kumar, N., & Ali, A. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.02.002 · Cited by 122
Urtti, A. O., Pipkin, J. D., Rork, G. S., Sendo, T., Finne, U., & Repta, A. J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90215-p · Cited by 121
Qu, X., Khutoryanskiy, V. V., Stewart, A., Rahman, S., Papahadjopoulos‐Sternberg, B., Dufès, C., McCarthy, D., WILSON, C. G., Lyons, R. T., Carter, K. C., et al. (2006) · Biomacromolecules · doi:10.1021/bm0604000 · Cited by 121
Self-citationAn Update on Ocular Surface Epithelial Stem Cells: Cornea and Conjunctiva
Ramos, T., Scott, D., & Ahmad, S. (2015) · Stem Cells International · doi:10.1155/2015/601731 · Cited by 120
A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease
Fan, Y., Zheng, M., Zhang, A. Y., & Han, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.039 · Cited by 120
Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control
Gawin-Mikołajewicz, A., Nartowski, K. P., Dyba, A. J., Gołkowska, A. M., Malec, K., & Karolewicz, B. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00650 · Cited by 119
Cell penetrating peptides in ocular drug delivery: State of the art
Pescina, S., Ostacolo, C., Gomez-Monterrey, I. M., Sala, M., Bertamino, A., Sonvico, F., Padula, C., Santi, P., Bianchera, A., & Nicoli, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.023 · Cited by 118
Huang, H., Wang, M., Chen, Z., Chiu, W.-Y., Chen, K.-H., Lin, I., Yang, W. V., Wu, C.-C., & Tseng, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s173198 · Cited by 114
Undefined role of mucus as a barrier in ocular drug delivery
Ruponen, M., & Urtti, A. O. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.032 · Cited by 112
Serious adverse events after cataract surgery
Stein, J. D. (2012) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3283524068 · Cited by 110
Apaolaza, P. S., Delgado, D., del Pozo‐Rodríguez, A., Rodríguez‐Gascón, A., & Solinís, M. Á. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.02.038 · Cited by 108
Dexamethasone nanowafer as an effective therapy for dry eye disease
Coursey, T. G., Henriksson, J. T., Marcano, D. C., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.007 · Cited by 105
Almeida, H., Amaral, M. H., Lobão, P., Silva, A. C., & Lobo, J. M. S. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3dp43 · Cited by 105
Shi, S., Zhang, Z., Luo, Z., Yu, J., Liang, R., Li, X., & Chen, H. (2015) · Scientific Reports · doi:10.1038/srep11337 · Cited by 101
Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system
Gugleva, V., Titeva, S., Rangelov, S., & Momekova, D. B. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.06.022 · Cited by 101
Lakhani, P. M., Patil, A., Wu, K.-W., Sweeney, C., Tripathi, S., Avula, B., Taskar, P., Khan, S. I., & Majumdar, S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118771 · Cited by 99
Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications
Umar, H., Wahab, H. A., Gazzali, A. M., Tahir, H., & Ahmad, W. (2022) · Polymers · doi:10.3390/polym14153118 · Cited by 99
Liu, D., Lian, Y., Fang, Q., Liu, L., Zhang, J., & Li, J. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.113 · Cited by 98
Liposomal stabilization of camptothecin's lactone ring
Burke, T. G., Staubus, A. E., Mishra, A. K., & Malak, H. M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00047a069 · Cited by 97
Akhter, S., Anwar, M., Siddiqui, M. A., Ahmad, I., Ahmad, J., Ahmad, M. Z., Bhatnagar, A., & Ahmad, F. J. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.048 · Cited by 97
Solute permeability of the corneal endothelium and Descemet's membrane
Kim, J. H., Green, K., Martínez, M., & Paton, D. J. (1971) · Experimental Eye Research · doi:10.1016/0014-4835(71)90143-6 · Cited by 93
Designing lipid nanoparticles for topical ocular drug delivery
Álvarez-Trabado, J., Diebold, Y., & Sanchez, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.017 · Cited by 92
Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds
Razavi, M. S., Ebrahimnejad, P., Fatahi, Y., D’Emanuele, A., & Dinarvand, R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.850757 · Cited by 92
Onugwu, A. L., Attama, A. A., Nnamani, P. O., Onugwu, S. O., Onuigbo, E. B., & Khutoryanskiy, V. V. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103527 · Cited by 92
Self-citationPotential Use of Nanostructured Lipid Carriers for Topical Delivery of Flurbiprofen
González‐Mira, E., Nikolic, S., García, M. L., Egea, M. A., Souto, E. B., & Calpena, A. C. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22271 · Cited by 91
Seedat, N., Kalhapure, R. S., Mocktar, C., Vepuri, S. B., Jadhav, M., Soliman, M. E. S., & Govender, T. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.053 · Cited by 91
The power of tears: how tear proteomics research could revolutionize the clinic
Zhou, L., & Beuerman, R. W. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1285703 · Cited by 91
Leonardi, A., Bucolo, C., Romano, G. L., Platania, C. B. M., Drago, F., Puglisi, G., & Pignatello, R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.061 · Cited by 90
Nanomicelle‐Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo
Weng, Y., Ma, X., Che, J., Li, C., Liu, J., Chen, S., Wang, Y., Gan, Y., Chen, H., Hu, Z., et al. (2017) · Advanced Science · doi:10.1002/advs.201700455 · Cited by 90
Ting, D. S. J., Cairns, J., Gopal, B. P., Ho, C. S., Krstić, L., Elsahn, A. F., Lister, M. M., Said, D. G., & Dua, H. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.715118 · Cited by 90
Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions
Popov, A. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2020.0022 · Cited by 89
Fu, T., Yi, J., Lv, S., & Zhang, B. (2016) · Journal of Liposome Research · doi:10.1080/08982104.2016.1224899 · Cited by 88
Sun, F., Zheng, Z., Lan, J., Li, X., Li, M., Song, K., & Wu, X. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1622608 · Cited by 85
Yu, Y., Chen, D., Li, Y., Yang, W., Tu, J., & Shen, Y. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1458923 · Cited by 85
Lancina, M. G., Singh, S., Kompella, U. B., Husain, S., & Yang, H. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00319 · Cited by 84
Wang, J., Li, B., Huang, D., Norat, P., Grannonico, M., Cooper, R. C., Gui, Q., Chow, W. N., Liu, X., & Yang, H. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130498 · Cited by 81
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2009) · Current Eye Research · doi:10.1080/02713680903017500 · Cited by 80
Self-citationLópez-Machado, A., Díaz‐Garrido, N., Cano, A. C., Espina, M., Badía, J., Baldomà, L., Calpena, A. C., Souto, E. B., García, M. L., & Sánchez‐López, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101698 · Cited by 80
Wang, R., Gao, Y., Liu, A., & Zhai, G. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1878366 · Cited by 78
Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77
Dendrimers for ocular drug delivery
Lancina, M. G., & Yang, H. (2017) · Canadian Journal of Chemistry · doi:10.1139/cjc-2017-0193 · Cited by 77
Eid, H. M., Naguib, I. A., Alsantali, R. I., Alsalahat, I., & Hegazy, A. M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.04.020 · Cited by 77
Maleimide-bearing nanogels as novel mucoadhesive materials for drug delivery
Tonglairoum, P., Brannigan, R. P., Opanasopit, P., & Khutoryanskiy, V. V. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02124g · Cited by 76
Self-citationAfarid, M., Mahmoodi, S., & Baghban, R. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01567-7 · Cited by 76
Ren, T., Lin, X., Zhang, Q., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00516 · Cited by 74
Hathout, R. M., Gad, H. A., Abdel-Hafez, S. M., Nasser, N., Mahdy, N. K., Ateyya, T., Amr, A., Yasser, N., Nasr, S., & Metwally, A. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.015 · Cited by 72
Toropainen, E., Fraser‐Miller, S. J., Novakovic, D., del Amo, E. M., Vellonen, K., Ruponen, M., Viitala, T., Korhonen, O., Auriola, S. O. K., Hellinen, L., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040452 · Cited by 72
The Effect of Silica Nanoparticles on Human Corneal Epithelial Cells
Park, J.-H., Jeong, H., Hong, J., Chang, M., Kim, M., Chuck, R. S. H., Lee, J. K., & Park, C.-Y. (2016) · Scientific Reports · doi:10.1038/srep37762 · Cited by 71
Tan, G., Li, J., Song, Y., Yu, Y., Liu, D., & Pan, W. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.08.035 · Cited by 70
Liu, Y., Kam, W. R., Ding, J., et al. (2014) · Toxicology · doi:10.1016/j.tox.2014.02.014 · Cited by 69
Khalil, I. A. H., Ali, I. H., & El-sherbiny, I. M. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0297 · Cited by 69
Lyu, Q., Peng, L., Hong, X., Fan, T., Li, J., Cui, Y., Zhang, H., & Zhao, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120682 · Cited by 69
Yousry, C., Elkheshen, S. A., El-Laithy, H. M., Essam, T. M., & Fahmy, R. H. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.01.013 · Cited by 68
Shape Dependence of Gold Nanoparticles on In Vivo Acute Toxicological Effects and Biodistribution
Sun, Y., Wang, C.-D., Zhang, X., Ren, L., & Tian, X. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3094 · Cited by 67
Crown Ethers: Novel Permeability Enhancers for Ocular Drug Delivery?
Morrison, P. W. J., Porfiryeva, N. N., Chahal, S., Анясович, С. И., Lacourt, C., Семина, И. И., Moustafine, R. I., & Khutoryanskiy, V. V. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00556 · Cited by 67
Self-citationFernandes, A. R., Sánchez‐López, E., dos Santos, T., García, M. L., Silva, A. M., & Souto, E. B. (2021) · Materials · doi:10.3390/ma14247541 · Cited by 67
Asasutjarit, R., Theerachayanan, T., Kewsuwan, P., Veeranodha, S., Fuongfuchat, A., & Ritthidej, G. C. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0290-4 · Cited by 65
Shah, T. J., Conway, M. D., & Peyman, G. A. (2018) · Clinical ophthalmology · doi:10.2147/opth.s165722 · Cited by 65
Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration
Bravo‐Osuna, I., Vicario‐de‐la‐Torre, M., Andrés‐Guerrero, V., Sánchez‐Nieves, J., Guzmán, M., de la Mata, F. J., Gómez, R., Heras, B. D. L., Argüeso, P., Ponchel, G., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00182 · Cited by 64
Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole
Kumar, R., & Sinha, V. R. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1185437 · Cited by 64
Shim, G., Choi, H., Lee, S. B., Choi, J., Yu, Y. H., Park, D.-E., Choi, Y., Kim, C., & Oh, Y. (2013) · Molecular Therapy · doi:10.1038/mt.2013.10 · Cited by 63
Ammar, H. O., Haider, M. A., Ibrahim, M., & Hoffy, N. M. E. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1259371 · Cited by 63
Ramsay, E., Ruponen, M., Picardat, T., Tengvall, U., Tuomainen, M. H., Auriola, S. O. K., Toropainen, E., Urtti, A. O., & del Amo, E. M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.061 · Cited by 63
Sharma, U. K., Verma, A., Prajapati, S. K., Pandey, H., & Pandey, A. C. (2014) · Applied Nanoscience · doi:10.1007/s13204-014-0300-y · Cited by 61
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Delgado, M. F., Abdelrahman, A. M., Terahi, M., Woll, J. J. M. Q., Gil‐Carrasco, F., Cook, C., Benharbit, M., Boisseau, S., Chung, E., Hadjiat, Y., et al. (2019) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s218277 · Cited by 61
Noreen, S., Ghumman, S. A., Batool, F., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.193 · Cited by 59
Maleimide-Decorated PEGylated Mucoadhesive Liposomes for Ocular Drug Delivery
Moiseev, R. V., Kaldybekov, D. B., Filippov, S. K., Rădulescu, A., & Khutoryanskiy, V. V. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c02086 · Cited by 58
Self-citationRastogi, V., Yadav, P., Porwal, M., Sur, S., & Verma, A. K. (2022) · International Journal of Polymeric Materials · doi:10.1080/00914037.2022.2158334 · Cited by 58
The Role of Surface Active Agents in Ophthalmic Drug Delivery: A Comprehensive Review
Ibrahim, S. S. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.01.016 · Cited by 57
Expression of Efflux Transporters in Human Ocular Tissues
Chen, P., Chen, H., Zang, X., Chen, M., Jiang, H., Han, S., & Wu, X. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052704 · Cited by 56
Brannigan, R. P., & Khutoryanskiy, V. V. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.04.050 · Cited by 56
Self-citationModi, D., Mohammad, Warsi, M. H., Garg, V., Bhatia, M., Kesharwani, P., & Jain, G. K. (2021) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2021.1932359 · Cited by 56
Terreni, E., Zucchetti, E., Tampucci, S., Burgalassi, S., Monti, D., & Chetoni, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020192 · Cited by 52
Alginate nanoparticles as ocular drug delivery carriers
Kianersi, S., Solouk, A., Saber‐Samandari, S., Keshel, S. H., & Pasbakhsh, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102889 · Cited by 52
Wang, J.-Y., Wang, Y., & Xia, M. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1698-9 · Cited by 50
Marcano, D. C., Shin, C. S., Lee, B., Isenhart, L. C., Liu, X., Li, F., Jester, J. V., Pflugfelder, S. C., Simpson, J. L., & Acharya, G. S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00488 · Cited by 44
Nanocomplexes based polyvinylpyrrolidone K-17PF for ocular drug delivery of naringenin
Wang, H., Li, X., Yang, H. D., Wang, J., Li, Q., Qu, R., & Wu, X. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119133 · Cited by 44
Tagalakis, A. D., Madaan, S., Larsen, S. D., Neubig, R. R., Khaw, P. T., Rodrigues, I. A. S., Goyal, S., Lim, K. S., & Yu‐Wai‐Man, C. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0425-3 · Cited by 43
Alharbi, W. S., & Hosny, K. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101710 · Cited by 43
Wu, B., Li, M., Li, K., Hong, W., Lv, Q., Li, Y., Xie, S., Han, J., & Tian, B. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120405 · Cited by 43
When nanotechnology meets the ocular surface
Bucolo, C., Maltese, A., & Drago, F. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.3.325 · Cited by 42
In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
Dukovski, B. J., Bračko, A., Šare, M., Pepić, I., & Lovrić, J. (2019) · Acta Pharmaceutica · doi:10.2478/acph-2019-0054 · Cited by 40
Lancina, M. G., Wang, J., Williamson, G. S., & Yang, H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00401 · Cited by 39
iRGD decorated liposomes: A novel actively penetrating topical ocular drug delivery strategy
Huang, H., Yang, X., Li, H., Lu, H., Oswald, J. T., Liu, Y., Zeng, J., Jin, C., Peng, X., Liu, J., et al. (2020) · Nano Research · doi:10.1007/s12274-020-2980-9 · Cited by 38
Josyula, A., Omiadze, R., Parikh, K. S., Kanvinde, P. P., Appell, M. B., Patel, P. A., Saeed, H. K., Sutar, Y. B., Anders, N. M., He, P., et al. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10238 · Cited by 38
Stati, G., Rossi, F., Trakoolwilaiwan, T., Tung, L. D., Mourdikoudis, S., Thanh, N. T. K., & Pietro, R. D. (2022) · Molecules · doi:10.3390/molecules27010282 · Cited by 38
Yan, R., Xu, L., Wang, Q., Wu, Z., Zhang, H., & Gan, L. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00370 · Cited by 36
Tavakoli, M., Mahboobian, M. M., Nouri, F., & Mohammadi, M. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1941461 · Cited by 33
A Review of Synthesis, Characterization and Applications of Functionalized Dendrimers
Ebelegi, A. N., Allen, E. T., Ayawei, N., & Wankasi, D. (2017) · American Journal of Polymer Science · Cited by 32
Lidich, N., Garti-Levy, S., Aserin, A., & Garti, N. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.063 · Cited by 32
Gerhart, J. V., Greenbaum, M., Casta, L., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239079 · Cited by 31
Xu, B., & Liu, T. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101792 · Cited by 31
Zhang, F., Chen, H., Lan, J., Song, K., & Wu, X. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108313 · Cited by 31
El-Gendy, M. A., Mansour, M., El-Assal, M. I. A., Ishak, R. A. H., & Mortada, N. D. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119313 · Cited by 29
Vollrath, A., Kretzer, C., Beringer-Siemers, B., Shkodra, B., Czaplewska, J. A., Bandelli, D., Stumpf, S., Hoeppener, S., Weber, C., Werz, O., et al. (2021) · Polymers · doi:10.3390/polym13152557 · Cited by 25
Multi-Layered Nanomicelles as Self-Assembled Nanocarrier Systems for Ocular Peptide Delivery
Mandal, A., Patel, P., Pal, D., & Mitra, A. K. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1267-x · Cited by 24
Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention
Garg, P., Venuganti, V. V. K., Roy, A., & Roy, G. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1690451 · Cited by 23
Nanotechnology-based formulations to amplify intraocular bioavailability
Kagkelaris, K., Panayiotakopoulos, G. D., & Georgakopoulos, C. D. (2022) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414221112356 · Cited by 23
Li, Q., Wu, X., Xin, S., Wu, X., & Lan, J. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106020 · Cited by 22
Güven, U. M., & Başaran, E. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102518 · Cited by 21
Eroglu, Y. I. (2017) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2017.1336043 · Cited by 19
Kalam, M. A., Iqbal, M., Alshememry, A. K., Alkholief, M. A., & Alshamsan, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071328 · Cited by 18
Baldino, L., & Reverchon, E. (2022) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2022.105673 · Cited by 17
Lactoferrin: potential functions, pharmacological insights, and therapeutic promises
Ahmed, K., Saikat, A. S. M., Moni, A., Kakon, S. A. M., Islam, M., & Uddin, M. J. (2021) · Journal of Advanced Biotechnology and Experimental Therapeutics · doi:10.5455/jabet.2021.d123 · Cited by 16
El-Haddad, M. E., Hussien, A. A., Saeed, H. M. S., & Farid, R. M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102787 · Cited by 16
Noske, W., Stamm, C., & Hirsch, M. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1092 · Cited by 14
Dourado, L. F. N., da Silva, C. N., Gonçalves, R. S., Inoue, T. T., de Lima, M. E., & Cunha-Júnior, A. D. S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103501 · Cited by 12
Li, Q., Xin, M., Wu, X., & Lei, B. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0417 · Cited by 11
Development of Lipid-Based Microsuspensions for Improved Ophthalmic Delivery of Gentamicin Sulphate
Onugwu, A. L., Agbo, C. P., Nwagwu, C. S., Uzondu, S. W., Echezona, A. C., Ogbonna, J. D., Kenechukwu, F. C., Umeyor, C. E., Uronnachi, E., Akpa, P. A., et al. (2021) · Therapeutic Delivery · doi:10.4155/tde-2021-0039 · Cited by 10
Self-citationKazi-Chishti, M., DHAKNE, R., & Dehghan, M. H. (2020) · Journal of Research in Pharmacy · doi:10.35333/jrp.2020.142 · Cited by 8
Osorno, L. L., Medina, J. D. R., Maldonado, D. E., Mosley, R. J., & Byrne, M. E. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0145 · Cited by 7
Cited by
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers
Shafiq, M., Rafique, M., Cui, Y., Pan, L., Do, C.-W., & Ho, E. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.041 · Cited by 67
Ch, S., Padaga, S. G., Ghosh, B., Roy, S., & Biswas, S. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120822 · Cited by 40
RetractedDong, X., Cong, K., Lu, Y., Yang, S., Sun, Y., Hao, J., Liu, Y., Zhang, Y., Liu, C., He, C., et al. (2026) · Small · doi:10.1002/smll.74981
Metadata
- Authors
- Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 354
- Pages
- 465-488
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W4316687599
- Cited by
- 350
- References
- 192
- FWCI
- 30.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.